Hawaii Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 13 (93% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 5,432
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 89.28%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 1,983
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 92.38%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 9.74% 7.06%
White, Hispanic/Latino Patients 1.60% 1.56%
Black/African American, Non-Hispanic/Latino Patients 0.48% 0.50%
Black/African American, Hispanic/Latino Patients 0.17% 0.10%
Asian Patients3 20.80% 23.20%
American Indian/Alaska Native Patients3 0.39% 0.50%
Native Hawaiian/Other Pacific Islander Patients3 49.58% 51.94%
Patients with More Than One Race3 7.55% 7.11%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.53% 0.71%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.96% 0.55%
Unreported/Refused to Report Race and Ethnicity 8.21% 6.76%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 661
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 88.25%
COVID-19 Immunization Series Completed 525
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 87.50%
COVID-19 Immunization Series Additional 2,596
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 82.63%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 9.83% 10.86% 14.71%
White, Hispanic/Latino Patients 1.51% 2.48% 1.43%
Black/African American, Non-Hispanic/Latino Patients 1.21% 0.38% 0.65%
Black/African American, Hispanic/Latino Patients 0.00% 0.38% 0.08%
Asian Patients3 12.56% 11.24% 26.23%
American Indian/Alaska Native Patients3 0.91% 0.19% 0.54%
Native Hawaiian/Other Pacific Islander Patients3 43.57% 47.81% 32.32%
Patients with More Than One Race3 12.25% 12.76% 8.28%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.82% 0.76% 0.46%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.36% 1.14% 1.46%
Unreported/Refused to Report Race and Ethnicity 14.98% 12.00% 13.83%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 7.69%
1 to 24 Hours 38.46%
More Than 24 Hours 46.15%
N/A 7.69%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 23.08%
Vaccine confidence 46.15%
Vaccine storage capacity 0.00%
Vaccine supply 7.69%
Other 7.69%
None 30.77%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 76.92%
Average Percent of Health Center Visits Conducted Virtually 28.46%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 23.08%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 13
Number of School-Based Vaccination Sites 3
Number of Family Vaccination Clinics 4

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 61.54%
Refer patients to another organization that provides monoclonal antibody therapies 30.77%
None 30.77%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 7.69%
Patient awareness/education 0.00%
Staffing capacity 23.08%
Therapy administration/onsite logistics 15.38%
Other 0.00%
None 69.23%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 7
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 54,256

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 85.71%
Provide to General Public Who Came to the Health Center 57.14%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 14.29%
Provide at Other Community Events 14.29%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 28.57%
Other 28.57%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 2
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 33.33%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 33.33%
White, Hispanic/Latino Patients 0.00%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 33.33%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 33.33%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 0.00%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022